Analyst
Samasa Capital
Equibles does not estimate personal net worth.
Bhavya is recorded as Analyst at Samasa Capital. Bhavya has spoken on 1 earnings call across 1 company, most recently for Gufic Biosciences Limited on August 17, 2026. The companies whose calls Bhavya spoke on are classified in the Healthcare sector.
“I just wanted to know two things on GLP. Are we also participating in terms of our own brand? And also, has the third-party GLP we were manufacturing started kind of coming into our revenues?”
Samasa Capital
Analyst
Transcript header (unverified)
Gufic Biosciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Gufic Biosciences Limited
